{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:49:32Z","timestamp":1761544172262,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bridget Bradley"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.japh.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T17:44:05Z","timestamp":1561398245000},"page":"S146-S150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center"],"prefix":"10.1016","volume":"59","author":[{"given":"Emily","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","key":"10.1016\/j.japh.2019.05.006_bib1"},{"issue":"1","key":"10.1016\/j.japh.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.ajp.159.1.5","article-title":"Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia","volume":"159","author":"Smith","year":"2002","journal-title":"Am J Psychiatry"},{"author":"Malani","key":"10.1016\/j.japh.2019.05.006_bib3"},{"issue":"1","key":"10.1016\/j.japh.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1185\/030079907X253771","article-title":"An international survey of sleeping problems in the general population","volume":"24","author":"L\u00e9ger","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.japh.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"11","key":"10.1016\/j.japh.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.japh.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2013a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"6","key":"10.1016\/j.japh.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119302250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:45:33Z","timestamp":1761543933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119302250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1544319119302250"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.006","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}